Heart pillows: Pressure can reduce pain for cardiac patients

Jeff.Mills
Submitted by Jeff.Mills on

Sneezing, coughing, movement are more manageable for patients

Open heart surgery—a serious but highly successful operation—can make everyday actions like coughing, deep breathing, sneezing, laughing, getting out of bed and even the hiccups uncomfortable for patients right after surgery. Open heart surgeries require dividing the sternum (chest cavity) to allow access to the heart, so the breastbone and chest area need extra support for up to three months following the procedure.

One of the ways patients have been able to reduce their discomfort after open heart surgery is with the use of a heart-shaped pillow—filled with firm stuffing, that can help provide comfort, reduce pain and protect the surgery’s incision site.

But how can a non-medicated pillow help with pain?

Heart pillows can help reduce pain after surgery

Because of the increased risk of pneumonia and respiratory issues after surgery, patients are asked to cough and breathe deeply frequently so their lung fully expand and to get rid of phlegm. As part of the recovery process, patients also breathe into a device called an incentive spirometer multiple times a day for the first month to keep their lungs healthy after surgery.

Having a heart-to-heart hug with these pillows can lessen pain and makes movement more manageable for patients who’ve recently undergone coronary artery bypass grafting, valve repair or valve replacement. Clasping the heart pillow offsets the pain and safeguards the incision site.

“Patients embrace the heart pillow whenever they need to brace themselves for movement that might cause pain or injury to the incision site. If your pain is well managed, the more you will be able complete breathing exercises and walking that are important to your recovery,” says cardiothoracic vascular surgeon Philip Bongiorno, MD.

Pressure helps protects the incision site

After open heart surgery, incision care is extremely important. Patients are instructed to avoid lifting anything that weighs more than 10 pounds, but research has found that a cough pushes about 60 pounds of pressure against the sternum, while a sneeze places 90 pounds of pressure in the same area.

Bursts of pressure that powerful might break internal wires from surgery that hold the breastbone together. If one of these vital wires breaks, the only way to fix it is undergoing another surgery.

When a patient holds the heart pillow tightly against his or her chest, the pillow provides an extra layer of pressure to counteract any jolting from a cough, sneeze or movement. It helps reduce pain because it holds the incision and sensitive skin surrounding the incision firmly in place.

So what’s in a pillow anyway?

Filled with firm stuffing, so a squeeze won’t squish them flat like a child’s stuffed animal, the red heart pillows measure about 18 inches wide and 12 inches tall. Each pillow features a printed diagram of the anatomy of the heart, which comes in handy during conversations when patients explain their procedure to friends and family. Genesis staff members often autograph the pillows and write well wishes to the patient making it a huggable memory book too.

Originally, Genesis handed out large teddy bears for the same purpose. The bear, nicknamed “Sir Coughs-A-Lot,” was replaced by the heart pillow in 2013, because the wide shape of the heart provides better chest coverage. Plus, patients report having an easier time using the heart-shaped pillow effectively.

Patients use tightly folded blankets in the hospital

Upon leaving Genesis Hospital, open-heart surgery patients often clutch heart-shaped pillows to their chest. Genesis nurses present the pillow to the patient when it’s time to leave the hospital and complete recovery at home. Waiting until the time of departure ensures that the pillow remains sanitary for the patient.

While recovering in the hospital, patients use tightly folded blankets to provide similar sternum support, gripping the folded blanket to buffer pressure, pain and pulling, and to protect against repeat surgeries.

The heart pillows have become a prized possession to many Genesis cardiac patients. Patients often regard these pillows as a trophy – they represent surviving a traumatic and life-saving surgery. Most patients express tremendous gratitude for the procedure, and for the pillow too.

Heart pillows for electrophysiology and cardiac cath lab patients

Patients who undergo procedures that open the sternum, like coronary artery bypass grafting, valve repair or valve replacement surgery, receive the larger, firm heart-shaped pillows, but Genesis cardiac patients with different types of procedures receive a different type of heart pillow.

A generous group of Genesis volunteers sews and donates smaller, softer heart-shaped pillows for patients who experience procedures in the Cath Lab or Electrophysiology Lab. These colorful pillows can come in solid colors or wild prints and patterns. The volunteers happily use whatever type of fabric they can find. These heart pillows prop up patients, provide comfort and offer a personal touch.

Each year, an average of 3,500 heart pillows go home with Genesis cardiac patients including the firm postoperative pillows and the soft ones made by volunteers. For cardiac patients, Genesis heart pillows offer a huggable memento that lasts long after scars heal.

Heart Pillows for Cardiac Patients

Heart patients reduce their discomfort after open heart surgery with the use of a post-operative heart-shaped pillow at Genesis HealthCare in Zanesville, Ohio.

Exclude From Search
No

New heart procedure at Genesis

Submitted by Anonymous (not verified) on

On June 1, Genesis HealthCare System became the first hospital in the region to perform WATCHMAN Implant procedures. The one-time, minimally invasive procedure can reduce the risk of stroke and eliminate the use of blood thinners for patients with atrial fibrillation not caused by a heart valve problem. The procedure is performed by Mohamed Ahmed, M.D., interventional cardiologist, and Shaun Bhatty, M.D., electrophysiologist, who are part of the Genesis Heart & Vascular Institute.

“By performing the WATCHMAN Implant procedure, we can reduce stroke risk and eliminate the use of blood thinners preventing the threat of uncontrolled bleeding. This improves our patients’ health outlook and state of mind. We are proud to continue bringing new advanced procedures to our community,” said Mohamed Ahmed, M.D.

The WATCHMAN Implant is inserted through a thin tube that runs from a blood vessel in the upper leg to the left atrial appendage of the heart. Once in place, the WATCHMAN Implant seals off the left atrial appendage, where 90% of stroke-causing blood clots come from within the heart. Most patients return home the day after the procedure.

With WATCHMAN, most patients can stop using blood thinners 45 days after the procedure. The WATCHMAN Implant is the only implant of its kind approved by the Food and Drug Administration. Over 100,000 people worldwide have received the WATCHMAN Implant.

Atrial fibrillation (AFib) is a common type of heart arrhythmia that causes the heart to beat irregularly. It occurs when upper chambers of the heart (right and left atria) no longer contract in coordination. This can allow blood clots to form, especially in the left atrial appendage.

Genesis HealthCare System - OG Image
Exclude From Search
No

Genesis HealthCare System receives Stroke Awards

Submitted by Anonymous (not verified) on

Zanesville, Ohio (Aug. 21, 2020) - Genesis HealthCare System received the American Heart Association/American Stroke Association's Get With The Guidelines® - Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital's commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

"Genesis HealthCare System is dedicated to providing high-quality care for our stroke patients by implementing the American Heart Association's Get With The Guidelines-Stroke initiative," said Keela Barker, director, Genesis Rehabilitation & Ambulatory Services. "The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines, ensuring our patients get the timely stroke care they need."

Genesis earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.

Genesis also received the Target: StrokeSM Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient's arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.

Additionally, Genesis HealthCare System received the Target: Type 2 Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed with more than 90% compliance for 12 consecutive months for the "Overall Diabetes Cardiovascular Initiative Composite Score."

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.

Exclude From Search
No

Genesis first in region to perform innovative procedure

Submitted by Anonymous (not verified) on

Zanesville, Ohio (Oct. 8) - Genesis HealthCare System's vascular surgery team recently started performing the TransCarotid Artery Revascularization (TCAR) procedure. TCAR is a less-invasive method for treating carotid artery disease where plaque builds up in one or both neck arteries and can cause strokes.

"With the addition of TCAR, we have yet another innovative procedure to reduce stroke risk. Stroke impacts approximately 800,000 Americans each year and is the fifth-highest killer in the United States. TCAR is revolutionary because it enables us to reverse blood flow temporarily, and filter plaque particles before they reach the brain, minimizing risks during the procedure," said Michael Kunstmann, D.O., fellowship-trained and board-certified vascular surgeon.

During the procedure, a small incision is made in the neck. A tube is inserted into the carotid artery and connected to equipment to direct blood flow away from the brain temporarily. The blood is filtered before returning to a vein in the groin. In addition to fewer risks during the TCAR procedure, a smaller incision is used to reduce scarring and procedure time is less than half compared to carotid endarterectomy. Most patients return home the day after the procedure.

 

Exclude From Search
No

The WATCHMAN™ Implant: What you need to know

Submitted by Anonymous (not verified) on

 

The WATCHMAN™ Implant: 10 Questions Answered

The WATCHMAN Implant can reduce your risk of stroke and eliminate your use of blood thinners if you have atrial fibrillation (AFib) not caused by a heart valve problem.

1. What is AFib?

It is a common type of heart arrhythmia that causes the heart to beat irregularly. It occurs when upper chambers of the heart (right and left atria) no longer contract in coordination.

2. What are the symptoms?

This can occur without symptoms or may make you feel tired, lightheaded, short of breath or a fluttering sensation in your chest.

3. Is AFib dangerous?

When your heart beats irregularly with AFib, it can lead to blood clots, especially in the left atrial appendage (LAA) of the heart. In this scenario, you are five times more likely to have a stroke than someone with a regular heartbeat. Although blood thinners can reduce your risk of stroke, medications create other dangers, including bleeding. Other factors that increase stroke risk include ages 75 and up, high blood pressure, heart failure, diabetes, cardiovascular disease and prior stroke.

4. How does WATCHMAN help?

The WATCHMAN Implant prevents blood clots in the LAA by closing it. The LAA is where 90% of stroke-causing blood clots come from in the heart.

5. Is WATCHMAN safe?

Over 300,000 people worldwide have received the WATCHMAN Implant. It is the only implant of its kind approved by the FDA. With all medical procedures, there are risks associated with the implant procedure and the use of the device. Talk to your doctor, so you thoroughly understand all of the risks and benefits associated with the WATCHMAN Implant.

6. What are typical results?

You may be able to stop using blood thinners 45 days after your implant. After one year, 99% of patients discontinued using blood thinners.

7. What happens during the procedure?

During this one-time, minimally invasive procedure, a narrow tube is inserted into a blood vessel in your upper leg and goes to your LAA. The WATCHMAN is inserted through the tube until it reaches the LAA, where it unfolds like an umbrella. A thin layer of tissue will grow over the surface of the implant within about 45 days.

General anesthesia is used, so you are asleep during the procedure.

8. How long will I be in the hospital?

You will likely return home the day after the procedure.

9. What happens after the procedure?

Your medications will be reevaluated with a goal to discontinue blood thinners within six months.

10. Who performs the procedure?

Trained and experienced physicians, Kinan Kassar, M.D., interventional cardiologist, and Shaun Bhatty, M.D., electrophysiologist, who are both part of the Genesis Heart & Vascular Group.

Make an appointment

Talk to your doctor to determine if the WATCHMAN Implant is right for you.

 

The WATCHMAN™ Implant
Exclude From Search
No

MitraClip™ Implant: What you need to know

Submitted by Anonymous (not verified) on

MitraClip™ Implant Questions and Answers

1. What is mitral valve regurgitation?

a. This occurs when the mitral valve flap in your heart does not work correctly, allowing blood to leak backwards into the heart.

2. Are there symptoms?

a. You may be symptom free, or suffer from one or more of the following including a mild cough, lightheadedness, fatigue, shortness of breath that increases with activity and lying down or rapid heartbeat.

3. Is mitral valve regurgitation dangerous?

a. There are two main forms of mitral regurgitation, classified based on the underlying cause:

  1. Primary (Degenerative) Mitral Regurgitation

    -This form is caused by structural abnormalities of the mitral valve itself, such as damage to the valve leaflets, chordae tendineae, or annulus.

    -Common causes include mitral valve prolapse, rheumatic heart disease, or infective endocarditis.

    -It is often referred to as degenerative mitral regurgitation

  2. Secondary (Functional) Mitral Regurgitation

    -In this type, the mitral valve is structurally normal, but problems with the left ventricle or atrium—such as dilation or dysfunction—prevent the valve from closing properly.

4. Who are candidates for MitraClip?

a. MitraClip can help, if you have degenerative mitral regurgitation and are considered high risk for surgery. MitraClip is a solution for functional mitral disease if treatments did not help.

5. What happens during the procedure?

a. The MitraClip implant is a one time, minimally invasive procedure. The implant is inserted through a vein in your upper leg and guided to your heart, where it is attached to your mitral valve.

General anesthesia is used so you will be asleep during the procedure.

6. How does MitraClip help?

a. After the MitraClip is attached to the malfunctioning mitral valve in your heart, it will help the valve to close properly and restore normal blood flow through the heart.

7. What happens after the procedure?

a. You will stay in the hospital for one to three days. After the implant, you will take a blood thinner and aspirin. A checkup will occur in 30 days and at one year.

8. Who is on the procedure team?

a. A trained and experienced team of physicians make up the MitraClip team. The team includes Kinan Kassar, M.D., Interventional Cardiologist, and Mahmoud Farhoud, M.D. Each of these physicians are part of the Genesis Heart & Vascular Group.

 

 

 

 

 

 

Mitra Clip

MitraClip™ Implant Questions and Answers

Exclude From Search
No

Advanced minimally invasive treatments tackle structural heart disease

Submitted by Anonymous (not verified) on

It's been said "it always seems impossible until it's done." This statement couldn't be truer for the advanced minimally invasive treatments used today for structural heart disease. As one of the most exciting and fastest growing fields in cardiovascular medicine, technological developments over the last decade have led to previously unthinkable procedures becoming a successful option for a wide range of patients with defects or disorders in their heart's structure.

Not all heart disease is the same

Eating healthy and exercising is important for preventing coronary heart disease, which is caused by plaque buildup in the arteries that can cause chest pain and even heart attack. But, structural heart disease is different.

A heart problem that is structural may be present at birth (congenital) causing conditions such as a hole within the chambers of the heart. Structural heart disease acquired through wear and tear due to aging and time can lead to a tight aortic valve (aortic stenosis), or a leaky heart valve (mitral valve regurgitation) causing some blood to leak backward through the valve.

For patients with severe aortic stenosis, or narrowing of the aortic valve, the only treatment option for the last 50 years has been open heart surgery. While open heart surgery may still be a solution for some patients, minimally invasive catheter-based therapies have made care easier, with fewer complications and quicker recoveries.

Minimally invasive evolution: TAVR

As the most common structural heart disease treated today, heart valve disease is being successfully managed with non-surgical minimally invasive procedures, including transcatheter aortic valve replacement (TAVR). An increasingly-popular alternative to surgical repair, TAVR is a proven alternative to more traditional aortic valve surgery for both the medium or high-risk patient, and has more recently expanded as an option for those at lower risk. In 2024, over 100,000 Transcatheter Aortic Valve Replacement (TAVR) procedures were performed in the United States, continuing the upward trend in adoption of this minimally invasive treatment for aortic valve stenosis.

TAVR is a complete paradigm shift. Often completed through a tiny nick in the groin or a small cut in the neck, TAVR is performed by using a tube called a catheter and tools that fit inside the catheter. By putting the catheter into a blood vessel, we move it through the blood vessel into the heart.

The catheter holds a new artificial valve, which is then implanted or deployed into the damaged aortic valve. As the artificial valve expands it takes the place of the damaged valve. The TAVR procedure repairs the heart valve without removing the damaged valve.

After an average one or two day stay in the hospital, TAVR patients can resume normal activities within a week following the procedure. TAVR was initially approved for high-risk patients in poor health who weren't considered good candidates for traditional open-heart surgery. Now, essentially anyone who has symptomatic aortic valve stenosis is a candidate for TAVR.

Signs it's time to take steps for healing

While some people with aortic valve stenosis may not experience symptoms for many years, the disease has typically progressed to an advanced stage by the time mild to severe symptoms are noticed. A wide range of warning signs that may indicate severe narrowing of the valve and treatment is necessary, include:

  • Abnormal heart sound (heart murmur) heard through a stethoscope
  • Chest pain (angina) or tightness with activity
  • Feeling faint or dizzy or fainting with activity
  • Shortness of breath, especially when after being active
  • Fatigue, especially during times of increased activity
  • Heart palpitations (sensations of a rapid, fluttering heartbeat)

Aortic valve stenosis may also lead to heart failure, with signs and symptoms of heart failure include fatigue, shortness of breath and swollen ankles and feet.

Studies show that 50% of patients who don't receive a valve replacement are unlikely to survive more than an average of two years after symptoms begin,. While the procedure isn't without its risks, including bleeding problems and stroke, any patient who has severe aortic stenosis should be considered for TAVR.

Ready to take the next step in your journey?

Make an appointment to see how Genesis HealthCare System can help

Beyond TAVR: MitraClip

As TAVR evolves for treatment of aortic valve narrowing, technology is addressing another form of structural heart disease: mitral regurgitation or leaky heart valve. Known as the MitraClip™, the innovative transcatheter device has been used since 2013 to provide relief of leaky heart valve without the risk of conventional surgery.

Five years later, research showed transcatheter mitral valve repair with the MitraClip significantly reduces hospitalization and all-cause mortality compared with medical therapy alone. In patients with heart failure and moderate-to-severe or severe mitral regurgitation who continue to have symptoms despite optimal medical therapy, MitraClip is a successful treatment option. In addition, the FDA's broadened approval of the device supports MitraClip as an option for a broad range of patients with mitral regurgitation.

People who have abnormalities of the mitral valve can develop heart failure symptoms such as shortness of breath, fatigue and swelling in the legs — signs the valve is leaking severely.

A minimally invasive catheter-based procedure, MitraClip treats a severely leaking mitral valve by inserting the implant through a catheter inserted in a vein in the upper leg and guided to the heart. Once the implant (a clip) is attached to the mitral valve it can then close properly to restore normal blood flow.

TAVR
Exclude From Search
No
Subscribe to Heart & Vascular